By using NSCLC clinical data from The Cancer Genome Atlas (TCGA) cohort, we found that the mRNA level of EIF4G1 were closely related to NSCLC patients’ overall survival through Kaplan‐Meier survival analyses, particularly in LUAD patients (Figure 1D). Here, EIF4G1 is linked to non-small cell lung carcinoma.